According to a study published in JAMA Network Open, July 2024, over 95% of patients with schizophrenia who received 6-month paliperidone palmitate long-acting injectable antipsychotics remained relapse-free for up to three years. That is a remarkable outcome for a condition where daily pill adherence alone produces relapse rates above 40%.
If you or someone you care about is managing schizophrenia, bipolar disorder, or a related condition, you may have heard a psychiatrist mention a “shot” as an alternative to daily oral medication. This article explains what depot antipsychotics are, how they differ from pills, how long the various formulations last, and what the experience of starting this type of treatment actually looks like.
What Are Depot Antipsychotics?
The Core Idea Behind Injectable Medication
Depot antipsychotics are antipsychotic medications formulated for slow, sustained release from an injection site into the bloodstream. Rather than taking a pill every day, a patient receives a single injection every two to four weeks, or in some cases every one to six months. The medication is absorbed gradually from muscle tissue, maintaining a stable therapeutic level around the clock.
The term “depot” comes from the French for “storehouse.” That is essentially what the injection site becomes: a slow-releasing reservoir of medication that keeps blood levels steady without requiring daily action from the patient.
The core clinical advantage is consistency. Oral antipsychotics create peaks and troughs depending on when doses are taken, whether they are taken with food, and whether any doses are missed. Long-acting depot antipsychotics eliminate that variability almost entirely, which translates directly into fewer relapses.
Who Are Depot Antipsychotics For?
Depot antipsychotic therapy is not only for patients who forget their pills. It is a clinically recommended option for:
- People with schizophrenia or schizoaffective disorder, especially after a first episode
- Patients who have relapsed after stopping or missing oral medication
- Those whose daily routine makes consistent pill-taking difficult
- Anyone who prefers the certainty of a scheduled injection over daily self-management
- Patients with bipolar I disorder who experience psychosis during manic episodes
The American Psychiatric Association recommends long-acting injectables for patients who prefer this format or have a history of uncertain adherence, and current research suggests that earlier use may actually improve long-term treatment outcomes, not just adherence.
How Do Antipsychotic Shots Work?
From Injection to Bloodstream
Most antipsychotic shots use an oil-based or microsphere formulation that releases medication slowly after an intramuscular injection, typically into the gluteal (buttock) or deltoid (shoulder) muscle. The active medication is the same compound found in the corresponding oral version, but the delivery vehicle changes everything about how it behaves in the body.
The release profile is predictable. Unlike an oral dose, which peaks in the bloodstream within hours and then falls, an injectable depot builds to a steady therapeutic level and maintains it through the entire dosing window. For patients on a two-week cycle, that means consistent coverage every day of those two weeks, regardless of what else is happening in their lives.
The Transition Period
Starting depot antipsychotic therapy usually involves an overlap period. Because most injectables take a few weeks to reach full therapeutic levels, oral medication continues alongside the first injection or two. Once stable levels are confirmed, the oral medication is tapered off. The clinical team manages this transition and monitors for both therapeutic response and early side effects throughout.
How Long Do Different Formulations Last?
This is one of the most common questions patients and families have. The range is wider than most people expect.
Medication | Brand Name | Dosing Interval | Generation |
Fluphenazine decanoate | Prolixin Decanoate | Every 2-4 weeks | First-gen (typical) |
Haloperidol decanoate | Haldol Decanoate | Every 4 weeks | First-gen (typical) |
Risperidone microspheres | Risperdal Consta | Every 2 weeks | Second-gen (atypical) |
Aripiprazole monohydrate | Abilify Maintena | Every 4 weeks | Second-gen (atypical) |
Paliperidone palmitate 1-month | Invega Sustenna | Every 4 weeks | Second-gen (atypical) |
Paliperidone palmitate 3-month | Invega Trinza | Every 3 months | Second-gen (atypical) |
Paliperidone palmitate 6-month | Invega Hafyera | Every 6 months | Second-gen (atypical) |
What Is the Longest-Acting Antipsychotic Available?
The longest-acting antipsychotic currently available is paliperidone palmitate 6-month formulation (Invega Hafyera), administered just twice per year. According to research published in the International Journal of Neuropsychopharmacology, 2023, it demonstrated non-inferiority to the 3-month formulation in preventing relapse across a multi-year study. Reaching this formulation requires patients to first tolerate and stabilize on the 1-month version, then the 3-month version, before stepping up.
Good Health Psych currently administers haloperidol decanoate, fluphenazine decanoate, and Risperdal Consta directly in the office at the Brooklyn location.
What Does Depot Antipsychotic Therapy Actually Feel Like?
The Injection Appointment
Most patients are surprised by how brief the appointment is. The injection itself takes only a few minutes. Haloperidol and fluphenazine decanoate are administered into the gluteal or deltoid muscle. Risperdal Consta requires refrigeration and reconstitution before administration, which is handled entirely by the clinical team.
Some patients experience mild soreness at the injection site for a day or two, particularly in the first couple of cycles. This typically lessens over time as the body adjusts.
Side Effects to Know About
Long-acting antipsychotic shots carry the same general side effect profile as their oral equivalents. The most relevant considerations:
- First-generation injectables (haloperidol, fluphenazine): higher risk of movement-related side effects such as stiffness and restlessness, managed through dose adjustment or add-on medication
- Second-generation injectables (risperidone, aripiprazole, paliperidone): lower movement-side-effect risk but more associated with weight gain and metabolic changes; regular bloodwork is standard
- Injection site reactions: temporary soreness or redness, usually resolving within 48 hours
- Delayed-onset side effects: because the medication releases slowly, side effects that do emerge may take longer to resolve after a dose change than with oral medication
The tradeoff most patients appreciate: the day-to-day mental burden of managing a daily medication disappears entirely. No pill organizers, no mid-day reminders, no anxious uncertainty about whether a dose was taken.
The Evidence Is Consistent: Fewer Relapses, Less Hospitalization
Patients who switch from oral antipsychotics to long-acting injectables show significantly better real-world outcomes. A naturalistic study of schizophrenia patients found a 71% reduction in average hospital admissions and a 29% improvement in global functioning after switching to injectable therapy.
For patients who have relapsed previously, or whose families have watched the cycle of stabilization and crisis repeat, depot antipsychotic therapy addresses the most common underlying cause: inconsistent medication levels. It is not a measure of last resort. For many people, it is simply the more effective and practical format.
Interested in whether long-acting injectable antipsychotics are right for you or a loved one? Schedule an appointment at Good Health Psych, same-day or next-day availability, to speak with a board-certified psychiatrist and review your full treatment picture.
FAQ
Depot antipsychotics are used primarily for schizophrenia, schizoaffective disorder, and bipolar I disorder with psychosis. They are also an option for any patient who has difficulty maintaining consistent oral antipsychotic therapy, regardless of the specific diagnosis.
It depends on the formulation. Some antipsychotic shots are given every two weeks, others once a month, once every three months, or twice a year. The prescribing psychiatrist selects the interval based on the medication, the patient’s stability, and practical considerations.
Paliperidone palmitate 6-month (Invega Hafyera) is currently the longest-acting antipsychotic formulation, requiring only two injections per year. Reaching this formulation requires prior stabilization on the 1-month and 3-month versions.
Not inherently. The side effect profile is broadly similar to that of the equivalent oral medication. The main difference is that because the medication releases slowly, side effects that do occur may take longer to resolve after a dose adjustment than they would with an oral formulation.
Missing an injection is less immediately critical than missing a daily pill, since medication from the previous dose is still circulating. That said, it should be rescheduled as soon as possible. The care team will advise whether any bridging with oral medication is needed in the interim.
Some benefit may be noticed within the first two to four weeks, but full therapeutic levels typically require two to three dosing cycles to stabilize. An overlap with oral medication is standard during this period to ensure continuous coverage.